Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2008; 14(24): 3908-3913
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3908
Figure 3
Figure 3 Videodensitometric measurements of liver normal parenchyma (white), tumor parenchyma (gray) and tumor boundary (black) before and after percutaneous transhepatic injection of contrast agent SonoVue® into the normal liver parenchyma near the VX2 tumors during PTL. aP < 0.05 vs respective pre-injection values (Dunnett).